- Home
- ACFN vs UNCY Comparison
ACFN vs UNCY Comparison
Compare ACFN & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACFN
- UNCY
- Stock Information
- Founded
- ACFN 1986
- UNCY 2016
- Country
- ACFN United States
- UNCY United States
- Employees
- ACFN N/A
- UNCY N/A
- Industry
- ACFN Military/Government/Technical
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- ACFN Consumer Discretionary
- UNCY Health Care
- Exchange
- ACFN Nasdaq
- UNCY Nasdaq
- Market Cap
- ACFN 76.5M
- UNCY 74.2M
- IPO Year
- ACFN N/A
- UNCY 2021
- Fundamental
- Price
- ACFN $29.77
- UNCY $3.87
- Analyst Decision
- ACFN
- UNCY Strong Buy
- Analyst Count
- ACFN 0
- UNCY 4
- Target Price
- ACFN N/A
- UNCY $63.75
- AVG Volume (30 Days)
- ACFN 25.8K
- UNCY 527.4K
- Earning Date
- ACFN 11-06-2025
- UNCY 11-12-2025
- Dividend Yield
- ACFN N/A
- UNCY N/A
- EPS Growth
- ACFN 1520.82
- UNCY N/A
- EPS
- ACFN 2.84
- UNCY N/A
- Revenue
- ACFN $13,202,000.00
- UNCY N/A
- Revenue This Year
- ACFN N/A
- UNCY N/A
- Revenue Next Year
- ACFN N/A
- UNCY $3,131.28
- P/E Ratio
- ACFN $10.50
- UNCY N/A
- Revenue Growth
- ACFN 50.98
- UNCY N/A
- 52 Week Low
- ACFN $17.22
- UNCY $3.40
- 52 Week High
- ACFN $33.00
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- ACFN N/A
- UNCY 34.49
- Support Level
- ACFN N/A
- UNCY $4.23
- Resistance Level
- ACFN N/A
- UNCY $4.43
- Average True Range (ATR)
- ACFN 0.00
- UNCY 0.20
- MACD
- ACFN 0.00
- UNCY -0.00
- Stochastic Oscillator
- ACFN 0.00
- UNCY 8.20
About ACFN Acorn Energy Inc. Common Stock
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.